{"id":9062,"date":"2020-04-29T09:19:28","date_gmt":"2020-04-29T07:19:28","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=9062"},"modified":"2022-02-02T13:22:41","modified_gmt":"2022-02-02T12:22:41","slug":"prof-dr-thomas-illig","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/prof-dr-thomas-illig\/","title":{"rendered":"Prof. Dr. Thomas Illig"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/a><\/span><\/div>

Prof. Dr. Thomas Illig participates in\u00a0RESIST research project A2.<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>

Our research focus in RESIST is the identification of structural and other genetic variants in persons with severe immune deficiencies. We work closely together with the clinics and institutes of Prof. Grimbacher (Freiburg) and Prof. Schmidt (MHH). Moreover the Hannover Unified Biobank (HUB) is deeply involved in establishing a control population of healthy elderly individuals as well as diseased cohorts for different viral infections in close cooperation with the MHH clinics of Dermatology (Prof. Werfel), Neurology (Prof. Stangel) and Rheumatology (Prof. Witte).<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/i><\/span>Contact<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

Prof. Illig and his team<\/h1><\/div>
<\/span><\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>

Prof. Dr. Thomas Illig – Curriculum Vitae<\/h1><\/div>
<\/div><\/div><\/div>

Current Position<\/h3><\/div>